Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion

Journal of Hazardous Materials

Volumn 244-245, Issue , 2013, Pages 259-267

  Samaras, Vasilios G ^a   Stasinakis, Athanasios S ^a   Mamais, Daniel ^b   Thomaidis, Nikolaos S ^c   Lekkas, Themistokles D ^a  

^a UNIVERSITY OF THE AEGEAN   (Greece)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Micropollutants; Occurrence; Risk assessment; Sorption; Treatment

Indexed keywords

AQUEOUS PHASE; AVERAGE CONCENTRATION; BISPHENOLS; DICLOFENAC; EMERGING CONTAMINANT; ENDOCRINE DISRUPTING CHEMICALS; ENDOCRINE DISRUPTING COMPOUND; KETOPROFEN; MASS BALANCE; MICROPOLLUTANTS; NAPROXENS; NONYLPHENOLS; OCCURRENCE; OPERATIONAL CONDITIONS; PHARMACEUTICALLY ACTIVE COMPOUNDS; REMOVAL EFFICIENCIES; REMOVAL MECHANISM; SLUDGE SAMPLES; TARGET COMPOUND; TREATED WASTEWATER; TREATMENT; TRICLOSAN; WASTEWATER TREATMENT PLANTS;

ANAEROBIC DIGESTION; PHENOLS; RISK ASSESSMENT; SORPTION;

WASTEWATER TREATMENT;

4,4' ISOPROPYLIDENEDIPHENOL; DICLOFENAC; ENDOCRINE DISRUPTOR; IBUPROFEN; KETOPROFEN; NAPROXEN; NONYLPHENOL; TRICLOSAN;

ANOXIC CONDITIONS; CONCENTRATION (COMPOSITION); DIGESTION; DRUG; ENDOCRINE DISRUPTOR; POLLUTANT; SAMPLING; SLUDGE; SORPTION; WASTEWATER; WATER TREATMENT;

ANAEROBIC DIGESTION; ARTICLE; BIODEGRADATION; BIOTRANSFORMATION; CONTROLLED STUDY; GREECE; SAMPLING; SLUDGE DIGESTION; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

ANAEROBIOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENDOCRINE DISRUPTORS; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

GREECE;

EID: 84871002201     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.11.039     Document Type: Article

References (43)

1. Pal A., Yew-Hoong Gin K., Yu-Chen Lin A., Reinhard M. Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects. Sci. Total Environ. 2010, 408:6062-6069.
2. Ratola N., Cincinelli A., Alves A., Katsoyiannis A. Occurrence of organic microcontaminants in the wastewater treatment process: a mini review. J. Hazard. Mater. 2012, 239-240:1-18.
3. Stasinakis A.S., Gatidou G., Mamais D., Thomaidis N.S., Lekkas T.D. Occurrence and fate of endocrine disrupters in Greek sewage treatment plants. Water Res. 2008, 42:1796-1804.
4. Lian J., Liu J.X., Wei Y.S. Fate of nonylphenol polyethoxylates and their metabolites in four Beijing wastewater treatment plants. Sci. Total Environ. 2009, 407:4261-4268.
5. Stasinakis A.S., Mermigka S., Samaras V.G., Farmaki E., Thomaidis N.S. Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes. Environ. Sci. Pollut. Res. 2012, 19:1574-1583.
6. Latorre A., Lacorte S., Barceló D. Presence of nonylphenol, octyphenol and bisphenol a in two aquifers close to agricultural, industrial and urban areas. Chromatographia 2003, 57:111-116.
7. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266:175-189.
8. Martín J., Camacho-Mũnoz D., Santos J.L., Aparicio I., Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. J. Hazard. Mater. 2012, 239-240:40-47.
9. Drèze V., Monod G., Cravedi J.P., Biagianti-Risbourg S., Le Gac F. Effects of 4-nonylphenol on sex differentiation and puberty in mosquitofish (Gambusia holbrooki). Ecotoxicology 2000, 9:93-103.
10. Birkett J.W., Lester J.N. Endocrine Disrupters in Wastewater and Sludge Treatment Processes 2003, CRC Press LLC, Florida, USA.
11. Rostkowski P., Horwood J., Shears J.A., Lange A., Oladapo F.O., Besselink H.T., Tyler C.R., Hill E.M. Bioassay-directed identification of novel antiandrogenic compounds in bile of fish exposed to wastewater effluents. Environ. Sci. Technol. 2011, 45:10660-10667.
12. Buser R., Poiger T., Muller M. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33:2529-2535.
13. Deblonde T., Cossu-Leguille C., Hartemann P. Emerging pollutants in wastewater: a review of the literature. Int. J. Hyg. Environ. Health 2011, 214:442-448.
14. Verlicchi P., Al Aukidya M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci. Total Environ. 2012, 429:123-155.
15. Miège C., Choubert J.M., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ. Pollut. 2009, 157:1721-1726.
16. Radjenović J., Petrović M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
17. Santos J.L., González M.D.M., Aparicio I., Alonso E. Monitoring of di-(2-ethylhexyl)phthalate, nonylphenol, nonylphenol ethoxylates, and polychlorinated biphenyls in anaerobic and aerobic sewage sludge by gas chromatography-mass spectrometry. Int. J. Environ. Anal. Chem. 2007, 87:1033-1042.
18. Stasinakis A.S. Review on the fate of emerging contaminants during sludge anaerobic digestion. Bioresour. Technol. 2012, 121:432-440.
19. Janex-Habibi M.L., Huyard A., Esperanza M., Bruchet A. Reduction of endocrine disruptor emissions in the environment: the benefit of wastewater treatment. Water Res. 2009, 43:1565-1576.
20. Paterakis N., Chiu T.Y., Koh Y.K.K., Lester J.N., McAdam E.J., Scrimshaw M.D., Soares A., Cartmell E. The effectiveness of anaerobic digestion in removing estrogens and nonylphenol ethoxylates. J. Hazard. Mater. 2012, 199-200:88-95.
21. Carballa M., Omil F., Alder A.C., Lema J.M. Comparison between the conventional anaerobic digestion of sewage sludge and its combination with a chemical or thermal pre-treatment concerning the removal of pharmaceuticals and personal care products. Water Sci. Technol. 2006, 53:109-117.
22. Lahti M., Oikari A. Microbial transformation of pharmaceuticals naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments. Arch. Environ. Contam. Toxicol. 2011, 61:202-210.
23. Samaras V.G., Thomaidis N.S., Stasinakis A.S., Lekkas T.D. An analytical method for the simultaneous trace determination of acidic pharmaceuticals and phenolic endocrine disrupting chemicals in wastewater and sewage sludge by gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2011, 399:2549-2561.
24. Ziylan A., Ince N.H. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J. Hazard Mater. 2011, 187:24-36.
25. Stasinakis A.S., Kordoutis C.I., Tsiouma V.C., Gatidou G., Thomaidis N.S. Removal of selected endocrine disrupters in activated sludge systems: effect of sludge retention time on their sorption and biodegradation. Bioresour. Technol. 2010, 101:2090-2095.
26. Céspedes R., Lacorte S., Ginebreda A., Barceló D. Occurrence and fate of alkylphenols and alkylphenol ethoxylates in sewage treatment plants and impact on receiving waters along the Ter River (Catalonia, NE Spain). Environ. Pollut. 2008, 153:384-392.
27. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006, 40:3297-3303.
28. Fernandez M.P., Ikonomou M.G., Buchanan I. An assessment of estrogenic organic contaminant in Canadian wastewaters. Sci. Total Environ. 2007, 373:250-269.
29. Gomez M.J., Martinez Bueno M.J., Lacorte S., Fernandez-Alba A.R., Aguera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66:993-1002.
30. Lagana A., Bacaloni A., Leva I.D., Faberi A., Fago G., Marino A. Analytical methodologies for determining the occurrence of endocrine disrupting chemicals in sewage treatment plants and natural waters. Anal. Chim. Acta 2004, 501:79-88.
31. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
32. Ferreira Da Silva B., Jelic A., Lopez-Serna R., Mozeto A.A., Petrovic M., Barcelo D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
33. European Commission Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commision Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market, Part II 2003, Office for Official Publications of the European Communities, Luxembourg.
34. Bolz U., Hagenmaier H., Korner W. Phenolic xenoestrogens in surface water, sediments, and sewage sludge from Baden-Wurttemberg south-west Germany. Environ. Pollut. 2001, 115:291-301.
35. Heidler J., Halden R.U. Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling. J. Environ. Monit. 2009, 11:2207-2215.
36. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Res. 2010, 44:658-668.
37. Nieto A., Borrull F., Pocurull E., Marcé R.M. Occurrence of pharmaceuticals and hormones in sewage sludge. Environ. Toxicol. Chem. 2010, 29:1484-1489.
38. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 2005, 39:2219-2228.
39. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 2005, 39:97-106.
40. Strenn B., Clara M., Gans O., Kreuzinger N. Carbamazepine, diclofenac, ibuprofen and bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Water Sci. Technol. 2004, 50:269-276.
41. Patureau D., Delgenes N., Delgenes J.P. Impact of sewage sludge treatment processes on the removal of the endocrine disrupters nonylphenol ethoxylates. Chemosphere 2008, 72:586-591.
42. Lu J., Jin Q., He Y., Wu J., Zhang W., Zhao J. Anaerobic degradation behavior of nonylphenol polyethoxylates in sludge. Chemosphere 2008, 71:345-351.
43. Gangadharan Puthiya Veetil P., Vijaya Nadaraja A., Bhasi A., Khan S., Bhaskaran K. Degradation of triclosan under aerobic, anoxic and anaerobic conditions. Appl. Biochem. Biotechnol. 2012, 167:1603-1612.